Yes. CStone Pharmaceuticals (2616.HK) passes the AAOIFI Shari’ah Standard 21 screen.
Not settled. CStone Pharmaceuticals (2616.HK) could not be confirmed either way under the Catholic screen based on the USCCB investment guidelines.
Yes. CStone Pharmaceuticals (2616.HK) passes the Biblically Responsible Investing (BRI) screen.